Research programme: small molecule therapeutics - ORIC Pharmaceuticals
Alternative Names: Research programme: small molecule therapeutics - program ALatest Information Update: 31 May 2023
At a glance
- Originator ORIC Pharmaceuticals
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Solid tumours